Villar Cristina Cunha, Dongari-Bagtzoglou Anna
Department of Periodontics, University of Texas Health Science Center at San Antonio School of Dentistry, San Antonio, Texas 78229, USA.
Expert Rev Mol Med. 2008 Oct 13;10:e29. doi: 10.1017/S1462399408000835.
The prevalence of oropharyngeal candidiasis continues to be high, mainly because of an increasing population of immunocompromised patients. Traditional treatment of oropharyngeal candidiasis has relied on the use of antimicrobial drugs. However, unsatisfactory results with drug monotherapy and the emergence of resistant strains have prompted investigations into the potential use of adjunctive immunoenhancing therapies for the treatment of these infections. Here we review the host-recognition systems of Candida albicans, the immune and inflammatory response to infection, and antifungal effector mechanisms. The potential of immune modulation as a therapeutic strategy in oropharyngeal candidiasis is also discussed.
口咽念珠菌病的患病率仍然很高,主要原因是免疫功能低下患者的数量不断增加。口咽念珠菌病的传统治疗依赖于抗菌药物的使用。然而,药物单一疗法效果不理想以及耐药菌株的出现促使人们研究辅助免疫增强疗法在治疗这些感染中的潜在用途。在此,我们综述白色念珠菌的宿主识别系统、对感染的免疫和炎症反应以及抗真菌效应机制。还讨论了免疫调节作为口咽念珠菌病治疗策略的潜力。